Assessment of Crohnʼs disease activity by confocal laser endomicroscopy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Confocal laser endomicroscopy (CLE) allows microscopic imaging within the mucosal layer of the gut during ongoing endoscopy. Different studies have addressed the potential of CLE for in vivo diagnosis of ulcerative colitis and microscopic colitis. However, there are no data on the utility of CLE for in vivo diagnosis of Crohn's disease (CD). The aim was to assess the clinical utility of CLE in patients with CD and to determine whether disease activity can be graded using CLE. METHODS: Consecutive patients with and without CD were enrolled. The colonic mucosa was examined by standard white-light endoscopy followed by CLE. The features seen on CLE were compared between CD patients and controls. RESULTS: In all, 76 patients with CD were screened, of whom 54 patients were included in the present study. Eighteen patients without inflammatory bowel disease (IBD) served as controls. A significantly higher proportion of patients with active CD had increased colonic crypt tortuosity, enlarged crypt lumen, microerosions, augmented vascularization, and increased cellular infiltrates within the lamina propria. In quiescent CD, a significant increase in crypt and goblet cell number was detected compared with controls. Based on our findings, we propose a Crohn's Disease Endomicroscopic Activity Score (CDEAS) for assessing CD activity in vivo. CONCLUSIONS: CLE has the potential to significantly improve diagnosis of CD compared with standard endoscopy. These findings should be evaluated in future prospective trials to assess the value of this newly developed CLE score for prediction of disease course and therapeutic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121 · cited 1×
“Therefore, only histopathology is currently able to reliably predict disease severity in these settings.(28,29) In the present study we aimed to overcome this limitation of current endoscopic techniques using endomicroscopy.”
Background
Cited by
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Self-citationFritscher-Ravens, A., Pflaum, T., Mösinger, M., Ruchay, Z., Röcken, C., Milla, P. J., Das, M., Böttner, M., Wedel, T., & Schuppan, D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.046 · Cited by 248
Quénéhervé, L., David, G., Bourreille, A., Hardouin, J. B., Rahmi, G., Neunlist, M., Brégeon, J., & Coron, E. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.006 · Cited by 68
Iacucci, M., Jeffery, L., Acharjee, A., Grisan, E., Buda, A., Nardone, O. M., Smith, S. C. L., Labarile, N., Zardo, D., Ungar, B., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac233 · Cited by 50
Next-generation endoscopy in inflammatory bowel disease
Zammarchi, I., Santacroce, G., & Iacucci, M. (2023) · Diagnostics · doi:10.3390/diagnostics13152547 · Cited by 28
“Moreover, even quiescent CD [60] and UC [62] patients may have chronic changes, especially when compared to healthy subjects.”
Background
Metadata
- Authors
- Neumann, H., Vieth, M., Atreya, R., Grauer, M., Siebler, J., Bernatik, T., Neurath, M. F., & Mudter, J.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12
- Volume
- 18
- Issue
- 12
- Pages
- 2261-2269
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2050478480
- Cited by
- 105
- References
- 3
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.